“Covishield”– the Oxford University-Astra Zeneca’s potential COVID-19 vaccine will be commercialized in 73 days and Indians will be inoculated free under the National Immunization Programme (NIP), said reports. After the phase III trials of the Oxford vaccine initiated in India handled by pharmaceutical giant ‘Serum’ this report developed. “The government has given us a ‘special manufacturing priority license’ and fast-tracked the trial protocol processes to get the trials completed in 58 days. By this, the first dosing is happening from today in the final phase (Phase III) and the second dosing will happen after 29 days. The final trial data will be out in another 15 days from the second dosing. By that time, we are planning to commercialise Covishield” top official of serum institute of india said.